Forskning
Udskriv Udskriv
Switch language
Rigshospitalet - en del af Københavns Universitetshospital
Udgivet

The European Cancer Patient's Bill of Rights, update and implementation 2016

Publikation: Bidrag til tidsskriftReviewForskningpeer review

  1. How I treat NTRK gene fusion-positive cancers

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  2. Hallmarks of glioblastoma: a systematic review

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  1. Early Postoperative 18F-FET PET/MRI for Pediatric Brain and Spinal Cord Tumors

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Hybrid PET/MRI imaging in healthy unsedated newborn infants with quantitative rCBF measurements using 15O-water PET

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. 18F-FET PET/MRI for CNS-tumors in children and adolescents

    Publikation: KonferencebidragKonferenceabstrakt til konferenceForskningpeer review

  4. Deep Learning Based Attenuation Correction of PET/MRI in Pediatric Brain Tumor Patients: Evaluation in a Clinical Setting

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. (18) F-FDG PET/CT for planning external beam radiotherapy alters therapy in 11% of 581 patients

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  • Liselotte Højgaard
  • Bob Löwenberg
  • Peter Selby
  • Mark Lawler
  • Ian Banks
  • Kate Law
  • Tit Albreht
  • Jean-Pierre Armand
  • Mariano Barbacid
  • Michèle Barzach
  • Jonas Bergh
  • David Cameron
  • Pierfranco Conte
  • Filippo de Braud
  • Aimery de Gramont
  • Francesco De Lorenzo
  • Volker Diehl
  • Sarper Diler
  • Sema Erdem
  • Jan Geissler
  • Jola Gore-Booth
  • Geoffrey Henning
  • Denis Horgan
  • Jacek Jassem
  • Peter Johnson
  • Stein Kaasa
  • Peter Kapitein
  • Sakari Karjalainen
  • Joan Kelly
  • Anita Kienesberger
  • Carlo La Vecchia
  • Denis Lacombe
  • Tomas Lindahl
  • Lucio Luzzatto
  • Rebecca Malby
  • Ken Mastris
  • Françoise Meunier
  • Martin Murphy
  • Peter Naredi
  • Paul Nurse
  • Kathy Oliver
  • Jonathan Pearce
  • Jana Pelouchov
  • Martine Piccart
  • Bob Pinedo
  • Gilly Spurrier-Bernard
  • Richard Sullivan
  • Josep Tabernero
  • Cornelis Van de Velde
  • Bert van Herk
  • Peter Vedsted
  • Anita Waldmann
  • David Weller
  • Nils Wilking
  • Roger Wilson
  • Wendy Yared
  • Christoph Zielinski
  • Harald Zur Hausen
  • Thierry Le Chevalier
  • Patrick Johnston
Vis graf over relationer

In this implementation phase of the European Cancer Patient's Bill of Rights (BoR), we confirm the following three patient-centred principles that underpin this initiative:The right of every European citizen to receive the most accurate information and to be proactively involved in his/her care.The right of every European citizen to optimal and timely access to a diagnosis and to appropriate specialised care, underpinned by research and innovation.The right of every European citizen to receive care in health systems that ensure the best possible cancer prevention, the earliest possible diagnosis of their cancer, improved outcomes, patient rehabilitation, best quality of life and affordable health care. The key aspects of working towards implementing the BoR are:Agree our high-level goal. The vision of 70% long-term survival for patients with cancer in 2035, promoting cancer prevention and cancer control and the associated progress in ensuring good patient experience and quality of life.Establish the major mechanisms to underpin its delivery. (1) The systematic and rigorous sharing of best practice between and across European cancer healthcare systems and (2) the active promotion of Research and Innovation focused on improving outcomes; (3) Improving access to new and established cancer care by sharing best practice in the development, approval, procurement and reimbursement of cancer diagnostic tests and treatments.Work with other organisations to bring into being a Europe based centre that will (1) systematically identify, evaluate and validate and disseminate best practice in cancer management for the different countries and regions and (2) promote Research and Innovation and its translation to maximise its impact to improve outcomes.

OriginalsprogEngelsk
TidsskriftESMO Open
Vol/bind1
Udgave nummer6
Sider (fra-til)e000127
ISSN2059-7029
DOI
StatusUdgivet - 2016

ID: 53403577